50 results on '"Margolis, David J."'
Search Results
2. Stasis dermatitis: A challenging patient journey.
- Author
-
Lebwohl, Mark, Kirsner, Robert S., Margolis, David J., Barankin, Benjamin, Hashimoto, Takashi, Canosa, Juliana M., and Cha, Amy
- Published
- 2023
- Full Text
- View/download PDF
3. Circulating endothelial precursor cells are associated with a healed diabetic foot ulcer evaluated in a prospective cohort study.
- Author
-
Margolis, David J., Mitra, Nandita, Hoffstad, Ole, Malay, D. Scot, Mirza, Ziad K., Lantis, John C., Lev‐Tov, Hadar A., Kirsner, Robert S., Ruhela, Deepa, Bhopale, Veena M., and Thom, Stephan R.
- Subjects
- *
BIOMARKERS , *ENDOTHELIAL cells , *WOUND healing , *RESEARCH , *FLOW cytometry , *STATISTICS , *CONFIDENCE intervals , *DIABETIC foot , *DESCRIPTIVE statistics , *RESEARCH funding , *ODDS ratio , *LONGITUDINAL method , *WOUND care - Abstract
The goal of this multicentre study was to evaluate whether circulating endothelial precursor cells and microparticles can predict diabetic foot ulcer healing by the 16th week of care. We enrolled 207 subjects, and 40.0% (28.4, 41.5) healed by the 16th week of care. Using flow cytometry analysis, several circulating endothelial precursor cells measured at the first week of care were associated with healing after adjustment for wound area and wound duration. For example, CD34+CD45dim, the univariate odds ratio was 1.19 (95% confidence interval: 0.88, 1.61) and after adjustment for wound area and wound duration, the odds ratio was (1.67 (1.16, 2.42) p = 0.006). A prognostic model using CD34+ CD45dim, wound area, and wound duration had an area under the curve of 0.75 (0.67, 0.82) and CD34+ CD45dim per initial wound area, an area under the curve of 0.72 (0.64, 0.79). Microparticles were not associated with a healed wound. Previous studies have indicated that circulating endothelial precursor cells measured at the first office visit are associated with a healed diabetic foot ulcer. In this multicentred prospective study, we confirm this finding, show the importance of adjusting circulating endothelial precursor cells measurements by wound area, and show circulating endothelial precursor cells per wound area is highly predictive of a healed diabetic foot ulcer by 16th week of care. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Further evidence that wound size and duration are strong prognostic markers of diabetic foot ulcer healing.
- Author
-
Margolis, David J., Mitra, Nandita, Malay, D. Scott, Mirza, Ziad K., Lantis, John C., Lev‐Tov, Hadar A., Kirsner, Robert S., and Thom, Stephan R.
- Subjects
- *
BIOMARKERS , *WOUND healing , *TRAUMATOLOGY diagnosis , *RESEARCH , *DIABETIC foot , *MACHINE learning , *PREDICTION models , *LONGITUDINAL method , *ALGORITHMS - Abstract
Diabetic foot ulcers (DFU) are a critical problem for those with diabetes mellitus. Predicting the healing likelihood of a DFU is important to implementing appropriate care, allocating resources, having access to advanced therapies, having successful clinical trials, calibrating clinical trial results, and providing information to administrative entities on patient and provider outcomes. Prognostic modelling can also be important when attempting to compare results across trials or care centres. In a prospective cohort study, we demonstrate and replicate that simple wound characteristics like wound area and wound duration can be used to predict wound healing by the 16th week of care. The models were based on previous literature and replicated using a machine learning algorithm. The use of wound duration and wound area in a prognostic model continues to be important when comparing study results, centre‐based outcomes, as well as designing clinical trials. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
5. Identification of HLA‐DPA1*01:03:01:57 and HLA‐DPA1*02:01:01:29 from a case–control study of atopic dermatitis.
- Author
-
Damianos, Georgios, Duke, Jamie L., Pagkrati, Ioanna, Margolis, David J., and Monos, Dimitri S.
- Subjects
ATOPIC dermatitis ,CASE-control method - Abstract
DPA1*01:03:01:57 and DPA1*02:01:01:29 differ by a single nucleotide from their closest references, DPA1*01:03:01:02 and DPA1*02:01:01:06. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. No Association of filaggrin copy number variation and atopic dermatitis risk in White and Black Americans.
- Author
-
Fulton, Rachel L., Margolis, David J., Sockler, Patrick G., Mitra, Nandita, Wong, Xuan Fei Colin Cornelius, and Common, John E.
- Subjects
- *
ATOPIC dermatitis , *FILAGGRIN , *AFRICAN Americans , *ODDS ratio , *RACIAL differences - Abstract
Atopic dermatitis (AD) is a chronic, inflammatory skin condition with a multifactorial pathophysiology. The filaggrin gene (FLG) has particularly been implicated given loss of function (LoF) mutations in this gene lead to skin barrier dysfunction and such mutations can increase a patient's likelihood of developing AD. FLG has intragenic copy number variation (CNV), which impacts the total amount of filaggrin produced. Previous research reported a dose‐dependent effect such that as amount of FLG increases, risk of AD decreases. To gain a better understanding, we evaluated FLG CNV in a large case‐control study of Whites and Blacks with and without AD. The goal of our study was to determine whether FLG CNV has a dose‐dependent effect on the risk of developing AD and to determine whether FLG CNV varies by race. The frequencies and odds ratios comparing a given CNV by race or race within those with AD did not significantly vary. It had been thought that FLG CNV might vary by race and represent an important association with AD in Black AD subjects. However, our work suggests that while there are racial differences with respect to CNV, these differences do not appear to explain AD risk. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Comment on El‐Heis et al.
- Author
-
Fuxench, Zelma Cheisa, Mitra, Nandita, and Margolis, David J.
- Subjects
DIRECTED acyclic graphs ,NEONATAL sepsis ,STREPTOCOCCUS agalactiae ,ECZEMA - Abstract
However, the use of a DAG can be problematic if the prior knowledge used to generate the DAG is incomplete.[2] As illustrated in figure 1, the DAG implies that maternal risk factors for receiving antibiotics and laxatives are the same. If we are correctly interpreting this statement, then the investigators did not find an association between maternal antibiotic use and childhood eczema prior to multivariable adjustment meaning that the relationships noted in the DAG did not help to explain why other studies did find a relationship between maternal antibiotic exposure and childhood eczema. In order to properly understand the relationship between maternal antibiotic use and the risk of childhood eczema, multivariable analyses could be essential due to the potential for treatment selection bias with respect to antibiotic use and confounding. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
8. Fish skin grafts compared to human amnion/chorion membrane allografts: A double‐blind, prospective, randomized clinical trial of acute wound healing.
- Author
-
Kirsner, Robert S., Margolis, David J., Baldursson, Baldur T., Petursdottir, Kristin, Davidsson, Olafur B., Weir, Dot, and Lantis, John C.
- Subjects
- *
AMNION , *BIOPSY , *CHORION , *COMPARATIVE studies , *CONFIDENCE intervals , *FISHES , *HOMOGRAFTS , *STATISTICAL sampling , *WOUND healing , *XENOGRAFTS , *RANDOMIZED controlled trials , *TREATMENT effectiveness , *PROPORTIONAL hazards models , *BLIND experiment , *CHRONIC wounds & injuries , *DESCRIPTIVE statistics - Abstract
Chronic, nonhealing wounds consume a great deal of healthcare resources and are a major public health problem, associated with high morbidity and significant economic costs. Skin grafts are commonly used to facilitate wound closure. The grafts can come from the patient's own skin (autograft), a human donor (allograft), or from a different species (xenograft). A fish skin xenograft from cold‐water fish (Atlantic cod, Gadus morhua) is a relatively recent option that shows promising preclinical and clinical results in wound healing. Chronic wounds vary greatly in etiology and nature, requiring large cohorts for effective comparison between therapeutic alternatives. In this study, we attempted to imitate the status of a freshly debrided chronic wound by creating acute full‐thickness wounds, 4 mm in diameter, on healthy volunteers to compare two materials frequently used to treat chronic wounds: fish skin and dHACM. The purpose is to give an indication of the efficacy of the two therapeutic alternatives in the treatment of chronic wounds in a simple, standardized, randomized, controlled, double‐blind study. All volunteers were given two identical punch biopsy wounds, one of which was treated with a fish skin graft and the other with dehydrated human amnion/chorion membrane allograft (dHACM). In the study, 170 wounds were treated (85 wounds per group). The primary endpoint was defined as time to heal (full epithelialization) by blinded assessment at days 14, 18, 21, 25, and 28. The superiority hypothesis was that the fish skin grafts would heal the wounds faster than the dHACM. To evaluate the superiority hypothesis, a mixed Cox proportional hazard model was used. Wounds treated with fish skin healed significantly faster (hazard ratio 2.37; 95% confidence interval: (1.75–3.22; p = 0.0014) compared with wounds treated with dHACM. The results show that acute biopsy wounds treated with fish skin grafts heal faster than wounds treated with dHACM. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
9. Adult and infantile seborrheic dermatitis: update on current state of evidence and potential research frontiers.
- Author
-
Rau, Akash, Silva, Genevieve S., Margolis, David J., and Chiesa Fuxench, Zelma C.
- Abstract
Seborrheic dermatitis (SD) is a highly prevalent dermatological condition globally. The condition demonstrates bimodal presentation with what is commonly thought to be two subtypes: adult/adolescent seborrheic dermatitis (ASD) and infantile seborrheic dermatitis (ISD). Despite the common prevalence of ASD and ISD, there remains uncertainty around the underlying pathogenetic mechanisms, risk factors, and appropriate classification of the disease(s). This narrative review summarizes the current understanding of the epidemiology, presentation, and pathogenetic factors like epidermal barrier dysfunction, lipid abnormalities, and cutaneous microbiome for ASD and ISD. Elements such as immune responsiveness, neuroendocrine factors, and genetics in these disease states are also investigated. Throughout our review, we highlight shared features and discrepancies between ASD and ISD that are present in the literature and discuss potential avenues for future research that explore these disease states. We aim to contribute to the medical discourse on ASD and ISD and increase awareness of the need for additional research around these conditions, ultimately informing better targeting of therapeutics moving forward. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. A qualitative study of the experience of lower extremity wounds and amputations among people with diabetes in Philadelphia.
- Author
-
Barg, Frances K., Cronholm, Peter F., Easley, Ebony E., Davis, Trocon, Hampton, Michelle, Malay, D. Scot, Donohue, Cornelius, Song, Jinsup, Thom, Stephen R., and Margolis, David J.
- Subjects
DIABETES complications ,TREATMENT of diabetic foot ,ADAPTABILITY (Personality) ,AMPUTATION ,AUTONOMY (Psychology) ,PEOPLE with diabetes ,FEAR ,INTERVIEWING ,LEG ,LIMB salvage ,RESEARCH methodology ,MORTALITY ,SCIENTIFIC observation ,QUALITY of life ,WOUNDS & injuries ,DISEASE relapse ,QUALITATIVE research ,JUDGMENT sampling ,DIABETIC foot ,TREATMENT effectiveness ,HEALTH literacy ,DATA analysis software ,PATIENTS' attitudes ,DISEASE complications - Abstract
The purpose of this study was to explore perceptions among people with type 2 diabetes about foot ulcers and lower extremity amputations. This was a qualitative observational study utilizing open-ended, semistructured interviews of 39 people with diabetes who were purposively selected because they had either a foot ulcer ( n = 19) or a lower extremity amputation ( n = 20). Interviews were audio-recorded, deidentified, and entered into NVivo 10.0 for coding and analysis. Our integrated analytic approach combined inductively and deductively derived codes that were applied to all transcripts. Coded data were summarized and examined for patterns. Participants' description of the relationship between diabetes and their foot ulcer or amputation revealed a limited understanding of the disease process. Disruption and loss of independence was expressed whether the person had a foot ulcer or an amputation. Treatment recommendations for foot ulcers were viewed by most as extremely difficult. Amputation was a feared outcome, but some learned to adapt and, at times felt that the amputation enhanced their quality of life. Clinicians have assumed that a focus on limb salvage is preferred over a major amputation. However, because of the complexity of care requiring frequent healthcare provider visits, the frequency of care failure, the frequency of recurrence, and mortality associated with having had a foot ulcer, it may be more appropriate for clinicians to prioritize quality-of-life salvage. Foot ulcer treatment failure may be due to a lack of providers' understanding of the impact of treatment on a patient's life. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
11. NOS1AP genetic variation is associated with impaired healing of diabetic foot ulcers and diminished response to healing of circulating stem/progenitor cells.
- Author
-
Margolis, David J., Hampton, Michelle, Hoffstad, Ole, Mala, D. Scot, Mirza, Ziad, Woltereck, Diana, Shannon, Steven, Troiano, Michael A., Mitra, Nandita, Yang, Ming, Bhopale, Veena M., and Thom, Stephen R.
- Subjects
- *
AMPUTATION , *BLOOD circulation , *FOOT ulcers , *GENES , *GENETICS , *LEG , *STEM cells , *WOUND healing , *DIABETIC foot , *DISEASE complications - Abstract
It is unclear why many with diabetes develop foot ulcers (DFU) and why some do not heal. It could be associated with genetic variation. We have previously shown that NOS1AP variation is associated with lower extremity amputation in those with diabetes and that circulating stem progenitor cell concentration (SPC) is associated with impaired foot ulcer healing in those with diabetes. The goal of this study was to determine if NOS1AP variation is associated with impaired wound healing and with SPC mobilization in those with DFU. In longitudinal cohort study we demonstrate that NOS1AP variants rs16849113 and rs19649113 are associated with impaired wound healing and with SPC mobilization in those with DFU. We believe that further study of NOS1AP is merited and that it NOS1AP might be associated with a functional impairment. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
12. Clinical interventions for venous leg ulcers: Proposals to improve the quality of clinical leg ulcer research.
- Author
-
Lazarus, Gerald S., Kirsner, Robert S., Zenilman, Jonathan, Valle, M. Frances, Margolis, David J., Cullum, Nicky, Driver, Vickie R., Gould, Lisa, Lindsay, Ellie, Tunis, Sean, Marston, William, Bass, Eric, Ennis, William, Davidson, Jeffrey, and Bowden, Jeremy
- Subjects
EVALUATION of clinical trials ,ULCER treatment ,LEG ulcers ,PUBLISHING ,CONFERENCES & conventions ,RESEARCH methodology ,MEDICAL literature ,MEDICAL protocols ,QUALITY assurance ,WOUND healing ,EVIDENCE-based medicine ,HUMAN research subjects ,PATIENT decision making ,STANDARDS ,OLD age ,DIAGNOSIS - Abstract
The present status of clinical leg ulcer healing research was reviewed by 25 experts over 2 days on September 28 and 29, 2015. Multiple clinical effectiveness reviews were presented suggesting that published clinical wound healing research often does not meet present (2015) evidence based standards. Specific areas requiring remediation were highlighted and approaches to overcoming existing challenges were proposed. Participants using anonymous voting technology developed an action plan to resolve perceived deficiencies. Statements were accepted if 75% of participants agreed. Older patients with a high frequency of comorbid conditions posed particular difficulties in designing clinical research protocols and better diagnostic categorization is necessary A standardized model template for collecting information about diagnosis and evaluation of the effect of interventions on healing of all types of leg ulcers was considered a high priority. Such a model template could be modified depending on the specific etiology of the leg ulcers. Generally agreed on quantifiable standards to establish degree of morbidity was considered a high priority. There was universal agreement that sources of funding and conflicts of interest needed to be disclosed in presentations and all publications. All clinical research studies should be registered with appropriate authorities. There was substantial enthusiasm for a clinical research network with quality standards for membership and an advisory research core available to investigators. Such a network should be funded and actively managed to insure long-term viability. The governance of such an entity needs to be established by the wound care community. The present trend to integrate patients into the clinical research process was endorsed and there was enthusiasm to develop patient advocacy for wound healing research. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
13. Variants in genes belonging to the fibroblast growth factor family are associated with lower extremity amputation in non-Hispanic whites: Findings from the chronic renal insufficiency cohort study.
- Author
-
Gupta, Jayanta, Mitra, Nandita, Townsend, Raymond R., Fischer, Michael, Schelling, Jeffrey R., and Margolis, David J.
- Subjects
DIABETES complications ,CHRONIC kidney failure ,CHI-squared test ,CONFIDENCE intervals ,ETHNIC groups ,FIBROBLASTS ,GENES ,GROWTH factors ,LEG amputation ,LONGITUDINAL method ,RESEARCH funding ,STATISTICS ,WOUND care ,DATA analysis ,GENOTYPES ,DIAGNOSIS - Abstract
Diabetes is the major risk factor for nontraumatic lower extremity amputation (LEA). The role of genetic polymorphisms in predisposing diabetics to impaired wound healing leading to LEA has not been sufficiently explored. We investigated the association between a set of genes belonging to the angiogenesis/wound repair pathway with LEA in the Chronic Renal Insufficiency Cohort, a study of adults with chronic kidney disease (CKD) that includes a subgroup with diabetes. This study was performed on 3,772 Chronic Renal Insufficiency Cohort participants who were genotyped on the ITMAT-Broad-CARe array chip. A total of 1,017 single-nucleotide polymorphisms (SNPs) in 22 genes belonging to the angiogenesis/would repair pathway were investigated. LEA was determined from patient self-report. The association between genetic variants and LEA status was examined using logistic regression and additive genetic models after stratifying the cohort by race/ethnicity and diabetic status. Unadjusted analyses as well as analyses adjusted for age, sex, estimated glomerular filtration rate, body mass index, peripheral vascular disease, hemoglobin A1c, and population stratification were performed. In non-Hispanic white participants with diabetes, rs11938826 and rs1960669, both intronic SNPs in the gene basic fibroblast growth factor-2 (FGF2), were significantly associated with LEA in covariate-adjusted analysis (OR: 2.83 (95% CI: 1.73, 4.62); p-value: 0.000034; Bonferroni adjusted p-value: 0.0006) and (OR: 2.61 (95% CI: 1.48, 4.61); p-value: 0.00095; Bonferroni adjusted p-value: 0.02). In the same subgroup, rs10883688, an FGF8 SNP of unknown functional effect, was also associated with LEA (OR: 1.72 (95% Confidence Interval: 1.14, 2.6); p-value: 0.00999; Bonferroni adjusted p-value: 0.04). No statistically significant associations were identified in the other ethnic groups. In conclusion, variant/s in FGF2 and FGF8 may predispose diabetics with CKD to LEA. Dysregulation of the FGF2 gene represents an opportunity to understand further, and possibly intervene upon, mechanisms of wound healing in diabetics with CKD. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
14. Statins may be associated with six-week diabetic foot ulcer healing.
- Author
-
Fox, Joshua D., Baquerizo ‐ Nole, Katherine L., Macquhae, Flor, Herskovitz, Ingrid, Freedman, Jeremy B., Vileikyte, Loretta, Margolis, David J., and Kirsner, Robert S.
- Subjects
LONGITUDINAL method ,MEDICAL cooperation ,SCIENTIFIC observation ,ORAL drug administration ,REGRESSION analysis ,RESEARCH ,WOUND healing ,TRAUMATOLOGY diagnosis ,SECONDARY analysis ,STATINS (Cardiovascular agents) ,DIABETIC foot ,TREATMENT effectiveness - Abstract
Diabetic foot ulcers (DFUs) affect 1.5 million Americans annually, of which only a minority heal with standard care, and they commonly lead to amputation. To improve care, investigations are underway to better understand DFU pathogenesis and develop more effective therapies. Some currently used medications may improve healing. One small, randomized clinical trial found statins improve DFU healing. In this secondary analysis of a large multisite prospective observational cohort of 139 patients with DFUs receiving standard care, we investigated whether there was an association between 6-week DFU wound size reduction and use of a variety of medications including alpha-blockers, beta-blockers, angiotensin converting enzyme inhibitors (ACEi) and statins. We found no significant ( p < 0.05) association between six-week wound reduction and use of any of the evaluated drugs; however, statins did trend toward an association ( p = 0.057). This suggests a potential benefit of statins on DFU healing, and larger, targeted studies are warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
15. Identification of Stevens-Johnson syndrome and toxic epidermal necrolysis in electronic health record databases.
- Author
-
Davis, Robert L., Gallagher, Mia A., Asgari, Maryam M., Eide, Melody J., Margolis, David J., Macy, Eric, Burmester, James K., Selvam, Nandini, Boscarino, Joseph A., Cromwell, Lee F., Feigelson, Heather S., Kuntz, Jennifer L., Pawloski, Pamala A., Penfold, Robert B., Raebel, Marsha A., Sridhar, Gayathri, Wu, Ann, La Grenade, Lois A., Pacanowski, Michael A., and Pinheiro, Simone P.
- Abstract
Background Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) carry a high mortality risk. While identifying clinical and genetic risk factors for these conditions has been hindered by their rarity, large electronic health databases hold promise for identifying large numbers of cases for study, especially with the introduction in 2008 of ICD-9 codes more specific for these conditions. Objective The objective of this study is to estimate the validity of ICD-9 codes for ascertaining SJS/TEN in 12 collaborating research units in the USA, covering almost 60 million lives. Methods From the electronic databases at each site, we ascertained potential cases of SJS/TEN using ICD-9 codes. At five sites, a subset of medical records was abstracted and standardized criteria applied by board-certified dermatologists to adjudicate diagnoses. Multivariate logistic regression was used to identify factors independently associated with validated SJS/TEN cases. Results A total of 56 591 potential cases of SJS/TEN were identified. A subset of 276 charts was selected for adjudication and 39 (of the 276) were confirmed as SJS/TEN. Patients with the ICD-9 codes introduced after 2008 were more likely to be confirmed as cases (OR 3.32; 95%CI 0.82, 13.47) than those identified in earlier years. Likelihood of case status increased with length of hospitalization. Applying the probability of case status to the 56 591 potential cases, we estimated 475-875 to be valid SJS/TEN cases. Conclusion Newer ICD-9 codes, along with length of hospitalization, identified patients with a high likelihood of SJS/TEN. This is important for identification of subjects for future pharmacogenomics studies. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
16. Online correction of licking-induced brain motion during two-photon imaging with a tunable lens.
- Author
-
Chen, Jerry L., Pfäffli, Oliver A., Voigt, Fabian F., Margolis, David J., and Helmchen, Fritjof
- Subjects
NEURAL circuitry ,NEURAL transmission ,NERVOUS system ,NEOCORTEX ,NEURONS - Abstract
Key points In order to understand the underlying behaviour of neuronal circuit dynamics, it is necessary to monitor brain activity in the awake, behaving animal., Licking to obtain water reward is an approach that is often used to measure an animal's decision during reward-based behaviour tasks., In head-fixed mice, licking produces stereotyped brain motion that interferes with two-photon calcium imaging of neuronal activity., We describe a method to provide online optical correction of licking-induced brain motion during two-photon imaging using refocusing with an electrically tunable lens., Online correction of licking-induced brain motion improves the measurement of neuronal activity during reward-based behaviour., Abstract Two-photon calcium imaging in awake, head-fixed animals enables the measurement of neuronal activity during behaviour. Often, licking for the retrieval of water reward is used as a measurable report of the animal's decision during reward-driven behaviour. However, licking behaviour can induce severe motion artifacts that interfere with two-photon imaging of cellular activity. Here, we describe a simple method for the online correction of licking-induced focus shifts for two-photon calcium imaging of neocortical neurons in the head-fixed mouse. We found that licking causes a stereotyped drop of neocortical tissue, shifting neurons up to 20 μm out of focus. Based on the measurement of licking with a piezo film sensor, we developed a feedback model, which provides a corrective signal for fast optical focus adjustments with an electrically tunable lens. Using online correction with this feedback model, we demonstrate a reduction of licking-related focus changes below 3 μm, minimizing motion artifact contamination of cellular calcium signals. Focus correction with a tunable lens is a simple and effective method to improve the ability to monitor neuronal activity during reward-based behaviour. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
17. Diabetes, lower extremity amputation, loss of protective sensation, and neuronal nitric oxide synthase associated protein in the Chronic Renal Insufficiency Cohort study.
- Author
-
Margolis, David J., Gupta, Jayanta, Thom, Stephen R., Townsend, Raymond R., Kanetsky, Peter A., Hoffstad, Ole, Papdopoulos, Maryte, Fischer, Michael, Schelling, Jeffrey R., and Mitra, Nandita
- Subjects
- *
DIABETES risk factors , *ACADEMIC medical centers , *ALLELES , *AMPUTATION , *DIABETIC neuropathies , *ENZYMES , *GENES , *GENETIC polymorphisms , *LEG , *LONGITUDINAL method , *MEDICAL cooperation , *NITRIC oxide , *RESEARCH , *RESEARCH funding , *DESCRIPTIVE statistics ,CHRONIC kidney failure complications - Abstract
Lower extremity amputation ( LEA) is a life-altering complication of diabetes. The goal of our study was to investigate the possibility that genetic variation in neuronal nitric oxide synthase associated protein ( NOS1AP ) is associated with LEA and diabetic peripheral neuropathy ( DPN). Our work used data from the Chronic Renal Insufficiency Cohort ( CRIC) study. CRIC is a multicenter investigation undertaken to pursue the relationship between chronic renal insufficiency and cardiovascular disease. We evaluated 3,040 CRIC study subjects; 1,490 individuals were African Americans and 1,550 were whites. LEA occurred in 162 (5.3%) subjects, 93 (6.2%) of African Americans and 69 (4.4%) of whites. In whites, NOS1AP single nucleotide polymorphism rs1963645 was most strongly associated with LEA (1.73 [1.23, 2.44]). In African Americans three NOS1AP single nucleotide polymorphisms were associated with LEA: rs6659759 (1.65 [1.21, 2.24]); rs16849113 (1.58 [1.16, 2.14]); rs880296 (1.54 [1.14, 2.10]). We tested a subset of 100 CRIC participants for DPN using Semmes- Weinstein filaments. DPN in those with diabetes was associated with rs1963645 (16.97 [2.38, 120.97]) in whites and rs16849113 and rs6659759 (3.62 [1.11, 11.83] and 3.02 [0.82, 11.12], respectively) in African Americans. In conclusion, this is one of the first studies to show that NOS1AP gene variants are associated with DPN and LEA. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
18. Care-Related Risk Factors for Hospital-Acquired Pressure Ulcers in Elderly Adults with Hip Fracture.
- Author
-
Baumgarten, Mona, Rich, Shayna E., Shardell, Michelle D., Hawkes, William G., Margolis, David J., Langenberg, Patricia, Orwig, Denise L., Palmer, Mary H., Jones, Patricia S., Sterling, Robert, Kinosian, Bruce P., and Magaziner, Jay
- Subjects
BEDSORES prevention ,BEDSORE risk factors ,HIP joint injury treatment ,HIP surgery ,PRESSURE ulcers ,CHI-squared test ,CONFIDENCE intervals ,EPIDEMIOLOGY ,FISHER exact test ,BONE fractures ,HIP joint injuries ,LONGITUDINAL method ,MEDICAL research personnel ,NURSES ,REGRESSION analysis ,RESEARCH funding ,SCALES (Weighing instruments) ,SURVIVAL analysis (Biometry) ,T-test (Statistics) ,DATA analysis ,DISEASE incidence ,SEVERITY of illness index ,DATA analysis software ,DESCRIPTIVE statistics ,OLD age - Abstract
Objectives To identify care-related factors associated with hospital-acquired pressure ulcers ( HAPUs). Design Prospective cohort study. Setting Nine hospitals in Baltimore Hip Studies network. Participants Six hundred fifty-eight individuals aged 65 and older who underwent surgery for hip fracture. Measurements Skin examinations at baseline and on alternating days until hospital discharge. Participants were deemed to have a HAPU if they developed one or more new Stage 2 or higher pressure ulcers ( PUs) during the hospital stay. Results Longer emergency department stays were associated with lower HAPU incidence (>4-6 hours: adjusted incidence rate ratio ( aIRR) = 0.68, 95% confidence interval (CI) = 0.48-0.96; >6 hours: aIRR = 0.68, 95% CI = 0.46-0.99, both vs ≤ 4 hours). Participants with 24 hours or longer between admission and surgery had a higher postsurgery HAPU rate than those with less than 24 hours ( aIRR = 1.62, 95% CI = 1.24-2.11). Surgery with general anesthesia had a lower postsurgery HAPU rate than surgery with other types of anesthesia ( aIRR = 0.66, 95% CI = 0.49-0.88). There was no significant association between HAPU incidence and timing of transport to the hospital, type of transport to the hospital, or surgery duration. Conclusion Most of the factors hypothesized to be associated with higher PU incidence were associated with lower incidence or were not significantly associated, suggesting that HAPU development may not be as sensitive to care-related factors as commonly believed. Rigorous studies of innovative preventive interventions are needed to inform policy and practice. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
19. Chronic imaging of cortical sensory map dynamics using a genetically encoded calcium indicator.
- Author
-
Minderer, Matthias, Liu, Wenrui, Sumanovski, Lazar T., Kügler, Sebastian, Helmchen, Fritjof, and Margolis, David J.
- Subjects
BRAIN imaging ,CEREBRAL cortex ,IMAGING systems in biology ,CALCIUM ,PROTEINS ,NEURONS ,LABORATORY mice - Abstract
Copyright of Journal of Physiology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2012
- Full Text
- View/download PDF
20. Pressure-Redistributing Support Surface Use and Pressure Ulcer Incidence in Elderly Hip Fracture Patients.
- Author
-
Rich, Shayna E., Shardell, Michelle, Hawkes, William G., Margolis, David J., Amr, Sania, Miller, Ram, and Baumgarten, Mona
- Subjects
PRESSURE ulcers ,BEDSORE risk factors ,CHI-squared test ,COMPUTER software ,CONFIDENCE intervals ,FISHER exact test ,BONE fractures ,HIP joint injuries ,PATIENT positioning ,POISSON distribution ,PROBABILITY theory ,RESEARCH ,RESEARCH funding ,T-test (Statistics) ,DATA analysis ,SECONDARY analysis ,DISEASE incidence - Abstract
To evaluate the association between pressure-redistributing support surface (PRSS) use and incident pressure ulcers in older adults with hip fracture. Secondary analysis of data from prospective cohort with assessments performed as soon as possible after hospital admission and on alternating days for 21 days. Nine hospitals in the Baltimore Hip Studies network and 105 postacute facilities to which participants were discharged. Six hundred fifty-eight people aged 65 and older who underwent surgery for hip fracture. Full-body examination for pressure ulcers; bedbound status; and PRSS use, recorded as none, powered (alternating pressure mattresses, low-air-loss mattresses, and alternating pressure overlays), or nonpowered (high-density foam, static air, or gel-filled mattresses or pressure-redistributing overlays except for alternating pressure overlays). Incident pressure ulcers (IPUs), Stage 2 or higher, were observed at 4.2% (195/4,638) of visits after no PRSS use, 4.5% (28/623) of visits after powered PRSS use, and 3.6% (54/1,496) of visits after nonpowered PRSS use. The rate of IPU per person-day of follow-up did not differ significantly between participants using powered PRSSs and those not using PRSSs. The rate also did not differ significantly between participants using nonpowered PRSSs and those not using PRSSs, except in the subset of bedbound participants (incidence rate ratio=0.3, 95% confidence interval=0.1-0.7). PRSS use was not associated with a lower IPU rate. Clinical guidelines may need revision for the limited effect of PRSS use, and it may be appropriate to target PRSS use to bedbound patients at risk of pressure ulcers. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
21. Vasculogenic stem cell mobilization and wound recruitment in diabetic patients: Increased cell number and intracellular regulatory protein content associated with hyperbaric oxygen therapy.
- Author
-
Thom, Stephen R., Milovanova, Tatyana N., Yang, Ming, Bhopale, Veena M., Sorokina, Elena M., Uzun, Günalp, Malay, D. Scot, Troiano, Michael A., Hardy, Kevin R., Lambert, David S., Logue, Christopher J., and Margolis, David J.
- Subjects
PROTEIN analysis ,STEM cells ,TREATMENT of diabetic foot ,ANALYSIS of variance ,BIOPSY ,DIABETES ,HYPERBARIC oxygenation ,PHLEBOTOMY ,DIGITAL photography ,RESEARCH funding ,WOUND healing ,REPEATED measures design ,PHYSIOLOGY - Abstract
Diabetic patients undergoing hyperbaric oxygen therapies (HBOT) for refractory lower extremity neuropathic ulcers exhibit more than a twofold elevation ( p=0.004) in circulating stem cells after treatments and the post-HBOT CD34 cell population contains two- to threefold higher levels of hypoxia inducible factors-1, -2, and -3, as well as thioredoxin-1 ( p<0.003), than cells present in blood before HBOT. Skin margins obtained from 2-day-old abdominal wounds exhibit higher expression of CD133, CD34, hypoxia inducible factor-1, and Trx-1 vs. margins from refractory lower extremity wounds and expression of these proteins in all wounds is increased due to HBOT ( p<0.003). HBOT is known to mobilize bone marrow stem cells by stimulating nitric oxide synthase. We found that nitric oxide synthase activity is acutely increased in patients' platelets following HBOT and remains elevated for at least 20 hours. We conclude that HBOT stimulates vasculogenic stem cell mobilization from bone marrow of diabetics and more cells are recruited to skin wounds. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
22. The differential effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers with respect to foot ulcer and limb amputation in those with diabetes.
- Author
-
Margolis, David J., Hoffstad, Ole, Thom, Stephen, Bilker, Warren, Maldonado, Arturo R., Cohen, Robert M., Aronow, Bruce J., and Crombleholme, Timothy
- Subjects
- *
DIABETES complications , *DIABETIC nephropathies , *DIABETIC foot , *AMPUTATION , *ANALYSIS of variance , *ACE inhibitors , *CONFIDENCE intervals , *ANTIHYPERTENSIVE agents , *LONGITUDINAL method , *RESEARCH funding , *MAXIMUM likelihood statistics , *PROPORTIONAL hazards models , *RETROSPECTIVE studies , *PHARMACOKINETICS , *PREVENTION - Abstract
Diabetic foot ulcers (DFU) or lower extremity amputation (LEA) are complications of diabetes. In those with diabetes, angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) are commonly used to prevent the progression of kidney disease. Recent studies have indicated that angiotensin may affect angiogenesis and wound repair. Our goal was to evaluate in those with diabetes the likelihood of developing a DFU or LEA among users of ACEi or ARB using a retrospective cohort design of general practices in the United Kingdom. We studied 40,342 individuals at least 35 years of age with diabetes who were first prescribed ACEi or ARB between 1995 and 2006. A total of 35,153 individuals were treated with ACEi, 12,437 individuals with ARB, and 7,310 both. The hazard ratio for DFU was 0.50 (95% confidence intervals: 0.43, 0.59), showing an increased risk of DFU for those using ACEi vs. ARB. The hazard ratio for LEA was 0.72 (0.48, 1.01). However, among those with lower extremity peripheral arterial disease the hazard ratio was 0.45 (0.22, 0.91) for the new onset of a LEA. In conclusion, among those with diabetes, exposure to ACEi as compared with ARB increases the risk of developing a DFU or LEA. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
23. The Frequency and Intensity of Topical Pimecrolimus Treatment in Children with Physician-Confirmed Mild to Moderate Atopic Dermatitis.
- Author
-
Kapoor, Roger, Hoffstad, Ole, Bilker, Warren, and Margolis, David J.
- Subjects
ATOPIC dermatitis ,ADRENOCORTICAL hormones ,SKIN inflammation ,PHYSICIAN-patient relations ,DRUG utilization - Abstract
Atopic dermatitis (AD) is often treated with multiple modalities, including topical medications such as corticosteroids and topical calcineurin inhibitors (TCIs). The aim of this study was to describe the natural history of the utilization characteristics of topical treatment in those with AD. We conducted a longitudinal study of the first 4,105 children with physician-confirmed mild to moderate AD enrolled in an ongoing postmarketing safety study of pimecrolimus. Information was obtained from participants every six months using a questionnaire. Drug utilization was solely determined by the physician and patient. Over the three years of our study, an increasing number of individuals reported at least 6 months of complete control of their disease, without the continued use of a topical medication. While all study participants used pimecrolimus at the start of the study less than 40% continued to use it after 3 years of study participation. If an individual was still using a topical medication after three years of follow-up, it was most likely a topical corticosteroid. For those who continued to use pimecrolimus, the use was limited to about 60 grams of pimecrolimus in 6 months. Community-based use of topical pimecrolimus to treat AD is limited both with respect to the duration of exposure and amount or total dose of the exposure. If a topical therapy is persistent, it is most likely to a topical corticosteroid. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
24. Preliminary development of a diabetic foot ulcer database from a wound electronic medical record: A tool to decrease limb amputations.
- Author
-
Golinko, Michael S., Margolis, David J., Tal, Adit, Hoffstad, Ole, Boulton, Andrew J. M., and Brem, Harold
- Subjects
- *
PATIENTS , *PEOPLE with diabetes , *AMPUTATION , *MEDICAL care , *MEDICAL personnel - Abstract
Our objective was to create a practical standardized database of clinically relevant variables in the care of patients with diabetes and foot ulcers. Numerical clinical variables such as age, baseline laboratory values, and wound area were extracted from the wound electronic medical record (WEMR). A coding system was developed to translate narrative data, culture, and pathology reports into discrete, quantifiable variables. Using data extracted from the WEMR, a diabetic foot ulcer-specific database incorporated the following tables: (1) demographics, medical history, and baseline laboratory values; (2) vascular testing data; (3) radiology data; (4) wound characteristics; and (5) wound debridement data including pathology, culture results, and amputation data. The database contains variables that can be easily exported for analysis. Amputation was studied in 146 patients who had at least two visits (e.g., two entries in the database). Analysis revealed that 19 (13%) patients underwent 32 amputations (nine major and 23 minor) in 23 limbs. There was a decreased risk of amputation, 0.87 (0.78, 1.00), using a proportional hazards model, associated with an increased number of visits and entries in the WEMR. Further analysis revealed no significant difference in age, gender, HbA1c%, cholesterol, white blood cell count, or prealbumin at baseline, whereas hemoglobin and albumin were significantly lower in the amputee group ( p<0.05) than the nonamputee group. Fifty-nine percent of amputees had histological osteomyelitis based on operating room biopsy vs. 45% of nonamputees. In conclusion, tracking patients with a WEMR is a tool that could potentially increase patient safety and quality of care, allowing clinicians to more easily identify a nonhealing wound and intervene. This report describes a method of capturing data relevant to clinical care of a patient with a diabetic foot ulcer, and may enable clinicians to adapt such a system to their own patient population. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
25. Pressure Ulcers in Elderly Patients with Hip Fracture Across the Continuum of Care.
- Author
-
Baumgarten, Mona, Margolis, David J., Orwig, Denise L., Shardell, Michelle D., Hawkes, William G., Langenberg, Patricia, Palmer, Mary H., Jones, Patricia S., McArdle, Patrick F., Sterling, Robert, Kinosian, Bruce P., Rich, Shayna E., Sowinski, Janice, and Magaziner, Jay
- Subjects
- *
PRESSURE ulcers , *HIP joint injuries , *BONE fractures , *CONTINUUM of care - Abstract
OBJECTIVES: To identify care settings associated with greater pressure ulcer risk in elderly patients with hip fracture in the postfracture period. DESIGN: Prospective cohort study. SETTING: Nine hospitals that participate in the Baltimore Hip Studies network and 105 postacute facilities to which patients from these hospitals were discharged. PARTICIPANTS: Hip fracture patients aged 65 and older who underwent surgery for hip fracture. MEASUREMENTS: A full-body skin examination was conducted at baseline (as soon as possible after hospital admission) and repeated on alternating days for 21 days. Patients were deemed to have an acquired pressure ulcer (APU) if they developed one or more new stage 2 or higher pressure ulcers after hospital admission. RESULTS: In 658 study participants, the APU cumulative incidence at 32 days after initial hospital admission was 36.1% (standard error 2.5%). The adjusted APU incidence rate was highest during the initial acute hospital stay (relative risk (RR)=2.2, 95% confidence interval (CI)=1.3–3.7) and during re-admission to the acute hospital (RR=2.2, 95% CI=1.1–4.2). The relative risks in rehabilitation and nursing home settings were 1.4 (95% CI=0.8–2.3) and 1.3 (95% CI=0.8–2.1), respectively. CONCLUSION: Approximately one-third of hip fracture patients developed an APU during the study period. The rate was highest in the acute setting, a finding that is significant in light of Medicare's policy of not reimbursing hospitals for the treatment of hospital-APUs. Hip fracture patients constitute an important group to target for pressure ulcer prevention in hospitals. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
26. Evaluation of the use of prognostic information for the care of individuals with venous leg ulcers or diabetic neuropathic foot ulcers.
- Author
-
Kurd, Shanu K., Hoffstad, Ole J., Bilker, Warren B., and Margolis, David J.
- Subjects
ULCERS ,LEG diseases ,PEOPLE with diabetes ,MEDICAL care ,WOUND healing - Abstract
This is a randomized factorial design clinical trial that investigates the efficacy and feasibility of providing prognostic information on wound healing. Prognostic information was provided based on baseline or 4-week wound characteristics. Healing rates were then determined at 24 weeks for venous leg ulcers and 20 weeks for diabetic neuropathic foot ulcers. Centers that had access to baseline information for venous leg ulcer prognosis had an odds ratio (OR) of healing of 1.42 (95% confidence interval [CI]: 1.03, 1.95) while centers that had access to information at 4 weeks had an OR of healing of 1.43 (95% CI: 1.05, 1.95) compared with controls. Diabetic neuropathic foot ulcer patients treated in centers that had been randomized to receive only 4-week prognostic information were more likely to heal than individuals seen in centers randomized to receive no intervention (OR 1.50, 95% CI: 1.05, 2.14). Our study found that it is feasible and efficacious to provide prognostic information on venous leg ulcers and diabetic neuropathic foot ulcers in a wound care setting using an existing administrative database. This intervention was easy to administer and likely had low associated costs. This method of dispersing prognostic information to healthcare providers should be expanded to include recently published treatment algorithms. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
27. Validity of pressure ulcer diagnosis using digital photography.
- Author
-
Baumgarten, Mona, Margolis, David J., Selekof, Joan L., Moye, Nancy, Jones, Patricia S., and Shardell, Michelle
- Subjects
- *
PRESSURE ulcers , *DIGITAL photography , *ULCER diagnosis , *DIAGNOSIS , *TRAUMATOLOGY diagnosis - Abstract
The purpose of this study was to evaluate the validity of digital photographs for the assessment of the presence of pressure ulcers stage 2 or higher. Participants were 48 patients (28 white and 20 black) with pressure ulcers identified in the course of a wound specialist's routine clinical practice at the University of Maryland Medical Center. One pressure ulcer and one unaffected skin area were photographed on each participating patient. The gold standard diagnosis (stage 2 pressure ulcer vs. stage 1 or no pressure ulcer) was recorded by the wound specialist based on bedside examination. The photographs were reviewed blindly by another wound expert. The sensitivity of the blinded assessment was 97% (95% confidence interval [CI] 91–100%). The specificity was 97% (95% CI 92–100%). The sensitivity and specificity were both 100% in the white patients. In black patients, the sensitivity and specificity were 92% (95% CI 75–100%) and 93% (95% CI 82–100%), respectively. These results suggest that the use of photographic images to assess the presence or absence of a pressure ulcer stage 2 or higher has a high degree of validity. Since blinded outcome assessment is one of the cornerstones of good clinical trial design, photography offers the potential to strengthen future studies. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
28. Association between serious ischemic cardiac outcomes and medications used to treat diabetes.
- Author
-
Margolis, David J., Hoffstad, Ole, and Strom, Brian L.
- Abstract
Purpose Data on cardiovascular outcomes among treated diabetics have been inconsistent. Our goal was to compare cardiovascular outcomes associated with different treatments for diabetes. Methods This is a retrospective cohort study of diabetic patients at least 40 years of age treated in general practices participating in The Health Information Network (THIN) data system between 2002 and 2006. Our primary outcome was serious atherosclerotic vascular disease of the heart. Results Among all diabetics ( N = 63 579), the fully adjusted hazard ratios of association with our outcome were 1.2 (1.1, 1.3) for insulin, 1.03 (0.97, 1.09) for sulfonylureas, 0.8 (0.7, 0.8) for biguanide, 1.2 (0.99, 1.5) for meglitinide, 0.5 (0.5, 0.6) for thiazolidinediones, and individually 0.6 (0.5, 0.6) for rosiglitazone, and 0.5 (0.4, 0.7) for pioglitazone. Among those individuals newly diagnosed and treated for diabetes after 2002 ( N = 13 576), the adjusted hazard ratios of association with our outcome were 2.4 (2.0, 2.9) for insulin, 1.4 (1.2, 1.7) for sulfonylureas, 0.5 (0.4, 0.5) for biguanide, 0.9 (0.4, 2.1) for meglitinide, 0.8 (0.7, 1.0) for thiazolidinediones, and individually 0.8 (0.6, 1.0) for rosiglitazone, and 0.9 (0.6, 1.4) for pioglitazone. Risk increased as total duration of therapy increased for insulin, sulfonylureas, and biguanide, but decreased with duration for rosiglitazone and pioglitazone. Conclusions Overall, insulin was associated with an increased risk of myocardial infarction. Its risk increased with longer use, and risk emerged with longer use of sulfonylureas and biguanide. Conversely, a protective effect emerged with longer use of rosiglitazone or pioglitazone. Copyright © 2008 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
29. Guidelines for the prevention of venous ulcers.
- Author
-
Robson, Martin C., Cooper, Diane M., Aslam, Rummana, Gould, Lisa J., Harding, Keith G., Margolis, David J., Ochs, Diane E., Serena, Thomas E., Snyder, Robert J., Steed, David L., Thomas, David R., and Wiersema‐Bryant, Laurel
- Subjects
ULCER prevention ,VEIN diseases ,HYPERTENSION ,EXERCISE ,LASER surgery - Abstract
The article offers suggestions for the prevention of venous ulcers. Compression stockings are suggested for patients with signs of increased ambulatory venous hypertension and postphlebitic syndrome. Exercise to increase calf muscle pump function is stated to be helpful in long-term maintenance and venous ulcer prevention. It is stated that surgery on the venous system such as venous ablation, endovenous laser ablation, and valvuloplasty can help decrease venous hypertension.
- Published
- 2008
- Full Text
- View/download PDF
30. Guidelines for the treatment of venous ulcers.
- Author
-
Robson, Martin C., Cooper, Diane M., Aslam, Rummana, Gould, Lisa J., Harding, Keith G., Margolis, David J., Ochs, Diane E., Serena, Thomas E., Snyder, Robert J., Steed, David L., Thomas, David R., and Wiersma‐Bryant, Laurel
- Subjects
VENOUS insufficiency ,VEIN diseases ,LEG ulcers ,PODIATRISTS ,PHYSICIANS ,NURSE practitioners ,EPIDEMIOLOGISTS ,SURGERY ,THERAPEUTICS - Abstract
The article presents the guidelines in treating patients with venous ulcers of the lower extremities. These are the developers of the guidelines including academicians, podiatrists, private practice physicians, nurse clinicians, research nurses, industrial scientists and an epidemiologist. The guidelines have been developed in eight categories including diagnosis, compression, infection control, wound bed preparation, dressings, surgery, adjuvant agents and long-term maintenance.
- Published
- 2006
- Full Text
- View/download PDF
31. Use of photographs for the identification of pressure ulcers in elderly hospitalized patients: validity and reliability.
- Author
-
Russell Localio, A., Margolis, David J., Kagan, Sarah H., Lowe, Robert A., Kinosian, Bruce, Abbuhl, Stephanie, Kavesh, William, Holmes, John H., Ruffin, Althea, and Baumgarten, Mona
- Subjects
- *
PRESSURE ulcers , *PHOTOGRAPHS , *SKIN injuries , *HOSPITAL patients , *WOUND healing , *WOUNDS & injuries - Abstract
To evaluate the ability of research nurses to identify pressure ulcers, the authors assembled digital photographs of the skin of 160 consenting elderly patients (80% African American, 63% women). The series included 39 photos of pressure ulcers, 109 of normal skin, and 12 of other skin conditions, determined by consensus by two experts (D.J.M. and S.H.K.). Photos were packaged electronically into eight blocks of 20, with pressure ulcer prevalence ranging from 20% to 30% per block. The eight blocks were duplicated to create two sets of 160 photos each. Each of six raters (experienced clinical research nurses), working independently, evaluated the 320 photos as if each photo depicted a different patient. For analysis, the ratings were collapsed into binary determinations (any pressure ulcer vs. none). The overall sensitivity and specificity of the ratings were 0.97 (95% confidence interval: 0.94, 0.98) and 0.81 (95% confidence interval: 0.77, 0.86), respectively. Rater-specific prevalence (range: 31.8–47.5%) exceeded the true prevalence (24.4%). Inter- and intrarater reliability coefficients were 0.69 and 0.84, respectively. Trained research nurses can accurately classify pressure ulcers from photographs, even when patients are largely non-White and the photographs depict pressure ulcers spanning all pressure ulcer stages. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
32. Risk of amputation in patients with diabetic foot ulcers: a claims-based study.
- Author
-
Markowitz, Jeffrey S., Gutterman, Elane M., Magee, Glenn, and Margolis, David J.
- Subjects
FOOT amputation ,DIABETIC foot ,PREOPERATIVE risk factors ,PERIPHERAL vascular diseases ,VASCULAR diseases ,WOUND healing ,REGENERATION (Biology) - Abstract
The objective of this study was to undertake a retrospective analysis of claims data of diabetic foot ulcer (DFU) patients to determine the rates of amputation and identify the risk and protective factors. Rates of amputation were calculated in patients diagnosed with DFU in the MEDSTAT Marketscan database between January 2000 and December 2002, who had prediagnosis coverage of 90 days. A nested case–control study was conducted using a 1 : 10 ratio of amputee cases to randomly selected nonamputee controls matched on follow-up days. The association of co-morbid conditions, demographic factors, and severity (5+ outpatient claims for DFU) on amputation was estimated by adjusted odds ratios (AOR) with 95% confidence intervals (CIs). The 5911 eligible patients yielded an incidence density rate of 2.30 amputations per 100 person years (95% CI = 1.91, 2.77). The 116 cases and 1153 controls averaged 307.3 and 308.5 observation days, respectively. Amputation was significantly increased by male gender (AOR 1.98), Charlson co-morbidity scores of 4–5 and 6+ (AOR = 2.89 and 5.36, respectively), renal disease (AOR = 2.11), peripheral vascular disease (AOR = 2.67), and 5+ outpatient DFU services (AOR = 2.17). Practitioners may consider more aggressive care and earlier referral to specialists for DFU patients who fit risk profiles for amputation, which include peripheral vascular disease, multiple co-morbid conditions, and repeated outpatient DFU services. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
33. Effectiveness of recombinant human platelet-derived growth factor for the treatment of diabetic neuropathic foot ulcers.
- Author
-
MARGOLIS, DAVID J., BARTUS, CYNTHIA, HOFFSTAD, OLE, MALAY, SCOT, and BERLIN, JESSE A.
- Subjects
- *
FOOT ulcers , *ULCER treatment , *PEOPLE with diabetes , *DIABETES , *WOUND care , *PLATELET-derived growth factor , *GROWTH factors , *THERAPEUTICS - Abstract
The goal of this study was to estimate the effectiveness in actual clinical practice of recombinant human platelet-derived growth factor (rhPDGF) for the treatment of diabetic neuropathic foot ulcer (DNFU). Previously published pivotal trials have shown that by the 20th week of care 35 percent more ulcers healed in the group randomized to receive rhPDGF than those who did not receive rhPDGF (i.e., a relative risk [RR] of about 1.35). This represents an estimate of the efficacy of rhPDGF under the tightly controlled conditions of randomized clinical trials. Treatment effectiveness under standard clinical practice was estimated in a retrospective cohort study, controlling for treatment selection bias using propensity scores. We noted 24,898 individuals with a DNFU, of whom 9.6 percent received rhPDGF. We successfully created a propensity score model that evenly balanced many wound characteristics between those who received rhPDGF and those who did not. We created five groups, which varied from those least likely to receive rhPDGF to those most likely to receive rhPDGF. The RR, controlling for the propensity, to receive rhPDGF for a healed wound after treatment with rhPDGF as compared with standard care was 1.32 (1.22, 1.38). With respect to amputation, the RR for undergoing amputation after receiving rhPDGF was 0.65 (0.54, 0.78) as compared with those who did not receive rhPDGF. Within the limitations of our study, rhPDGF is more effective than standard therapy in both helping a wound to heal and preventing amputation, and its effect is similar to the efficacy estimates from previously published randomized controlled trials. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
34. Diabetic neuropathic foot ulcers and amputation.
- Author
-
Margolis, David J., Allen‐Taylor, Lynne, Hoffstad, Ole, and Berlin, Jesse A.
- Subjects
- *
ULCERS , *FOOT diseases , *DIABETES complications , *PEOPLE with diabetes , *FOOT amputation , *AMPUTATION , *NEUROPATHY - Abstract
A neuropathic foot ulcer is a severe complication of diabetes that can result in a more severe complication, a lower extremity amputation. We conducted a cohort study of 24,616 individuals with a diabetic neuropathic foot ulcer treated within a multicenter wound care network. A total of 1653 (6.7%) individuals had an amputation and 46.3% of these amputations were of a toe or ray (minor amputation). In the more than 10-year follow-up period that we studied, the percentage of those who had an amputation varied between 5.6% and 8.4%. Of those who had an amputation, the percentage that had a minor amputation increased over time from 4.0% in the earliest years to more than 60% in the later years of observation. The single most important determinant of amputation was the observation of fascia, tendon, and bone at the initial assessment. In conclusion, about 7% of those with a diabetic neuropathic foot ulcer will have an amputation and in the past 10 years there has been a remarkable increase in the number of minor as compared to major amputations. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
35. Comparative cardiac safety of low-dose thioridazine and low-dose haloperidol.
- Author
-
Hennessy, Sean, Bilker, Warren B., Knauss, Jill S., Kimmel, Stephen E., Margolis, David J., Morrison, Mary F., Reynolds, Robert F., Glasser, Dale B., and Strom, Brian L.
- Subjects
DRUGS ,ARRHYTHMIA ,THIORIDAZINE ,DRUG prescribing ,DRUG dosage ,PHARMACEUTICAL industry - Abstract
To compare the rate of ventricular arrhythmia, sudden death and unexplained or unattended death among users of thioridazine and haloperidol. Observational cohort study of thioridazine and haloperidol users in the UK General Practice Research Database (GPRD) using data from 1987 through 29 June 2000. Patients were followed for 30 days following each study prescription. The event of interest was a diagnosis of ventricular arrhythmia, sudden death, or unexplained or unattended death. Cox regression was used to calculate rate ratios (RRs) and 95% confidence intervals (CIs), to examine potential confounding factors, and to examine dose–response relationships. Use of thioridazine and haloperidol in the GPRD was primarily in older patients, at low dose (median daily dose 31 mg thioridazine, 1.8 mg haloperidol). There was no association between thioridazine use and the rate of ventricular arrhythmia, sudden death, and unexplained or unattended death (adjusted RR 0.9, 95% CI 0.7, 1.1). The rate did not appear to increase with dose for either drug over the range observed. These results suggest that low-dose thioridazine and haloperidol have similar cardiac safety. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
36. Original Research Articles – Clinical Science The accuracy of venous leg ulcer prognostic models in a wound care system.
- Author
-
Margolis, David J., Allen‐Taylor, Lynne, Hoffstad, Ole, and Berlin, Jesse A.
- Subjects
- *
WOUND care , *BANDAGES & bandaging , *LOGISTIC regression analysis , *CLINICAL trials , *WOUND healing ,LEG ulcers - Abstract
Venous leg ulcers are among the most common chronic wounds. Treatment is commonly with a limb compression bandage. Previous small, often single-center, studies have shown that it is possible to predict which wounds are likely to respond to compression therapy. We designed this cohort study using a dataset of over 20,000 individuals with a venous leg ulcer to investigate the accuracy of several prognostic models. Creating complex models using logistic regression, as well as simply counting prognostic factors, we show that initial measures of wound size and duration accurately predict, as measured by area under the receiver operator curve and Brier score, who will heal by the 24th week of care. For example, a wound that is less than 10 cm2 and less than 12 months old at the first visit has a 29 percent chance of not healing by the 24th week of care, while a wound greater than 10 cm2 and greater than 12 months old has a 78 percent chance of not healing. Ultimately, these models can be applied by a clinician to help determine whom to continue to treat with standard care and perhaps whom to treat with adjuvant therapies. They may also aid in the design of clinical trials. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
37. Clinical Protocol: Phase I trial to evaluate the safety of H5.020CMV.PDGF-B for the treatment of a diabetic insensate foot ulcer.
- Author
-
Margolis, David J, Crombleholme, Timothy, and Herlyn, Meenhard
- Subjects
- *
PLATELET-derived growth factor , *GENE therapy , *WOUND healing , *CLINICAL trials , *SECRETION - Abstract
Most patients with chronic wounds fail to heal in a reasonable period of time. Despite considerable advances in elucidating the molecular basis of wound repair, attempts at developing new therapies have been disappointing. In fact, in the few studies where cytokine growth factors have been efficacious, their effect has been dramatically less than would have been predicted from animal studies. We hypothesize that platelet-derived growth factor-BB, a growth factor associated with wound healing, when produced in large quantities within the wound bed due to adenovirus mediated gene overexpression by the cells of the wound bed will dramatically enhance wound healing. Simply stated, we plan to insure the delivery of the growth factor by using gene therapy techniques so that cells locally involved in the wound healing process will temporarily increase their production of platelet-derived growth factor-BB. We present the first step in the series of human investigations to test this hypothesis which is a phase I clinical trial. Our proposed study is designed to assess local and systemic toxicity, and the feasibility of using the maximum tolerated dose of H5.020CMV.PDGF-b associated with in vivo platelet-derived growth factor-BB gene transduction via an intraulcer injection of H5.020CMV.PDGF-b in patients with a diabetic insensate foot ulcer. [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
38. The accuracy of using a wound care specialty clinic database to study diabetic neuropathic foot ulcers.
- Author
-
Kantor, Jonathan and Margolis, David J
- Subjects
- *
FOOT ulcers , *ELECTRONIC health records , *EPIDEMIOLOGY , *WOUNDS & injuries , *DISEASE risk factors - Abstract
Few epidemiologic studies have examined the effect of clinical risk factors on the probability that a patient with a chronic wound will heal or develop another wound. Curative Health Services maintains one of the few databases that contain detailed patient record information on patients with chronic wounds. The purpose of this study was to evaluate the reliability and validity of using this database to study individuals with diabetic neuropathic foot ulcers. 154 patient medical records were randomly selected from the database and abstracted using a standardized questionnaire and protocol. We assessed three key variables: diagnosis of diabetic neuropathic foot ulcer, whether the patient healed, and if the patient received an autologous product called platelet releasate. These variables in the database very accurately agreed with the information in the patient medical records, with positive predictive values of 98% (95% confidence interval [0.89, 0.99]), 93% (95% confidence interval [0.68, 0.99]), and 100%, respectively. We have shown that, with respect to these three variables, the database is very accurate when compared to the medical record. It therefore represents a valuable tool with which to study patients with diabetic insensate foot ulcers. [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
39. Filaggrin-2 barrier protein inversely varies with skin inflammation.
- Author
-
Seykora, John, Dentchev, Tzvete, and Margolis, David J.
- Subjects
FILAGGRIN ,IMMUNOSTAINING ,GENE expression ,ATOPIC dermatitis ,SKIN inflammation - Abstract
The article examines the immunohistochemical staining of filaggrin-2 gene (FLG2) in skin inflammation. The inverse association of the intensity of the staining with local inflammation is noted. The gene is found to be variably expressed in the stratum corneum of dermatitic skin. Variation in FLG2 immunohistochemical staining is also found with skin inflammatory response in those with atopic dermatitis.
- Published
- 2015
- Full Text
- View/download PDF
40. Health literacy and diabetic foot ulcer healing.
- Author
-
Margolis, David J., Hampton, Michelle, Hoffstad, Ole, Scot Malay, D., and Thom, Stephen
- Subjects
- *
CHI-squared test , *STATISTICAL correlation , *LONGITUDINAL method , *QUESTIONNAIRES , *REGRESSION analysis , *RESEARCH funding , *T-test (Statistics) , *WOUND healing , *DIABETIC foot , *CROSS-sectional method , *HEALTH literacy , *DESCRIPTIVE statistics - Abstract
ABSTRACT The adherence by patients to diabetic foot ulcer therapy is often difficult. The goal of this study was to begin to understand how a patient's health literacy affects their foot ulcer management decisions. Initially using a cross-sectional study design, we evaluated diabetics with foot ulcers within 4 weeks of being asked to participate in a longitudinal study. We assessed health literacy using measures of general health literacy, diabetes health literacy, diabetes self-efficacy, and diabetes numeracy. Individuals enrolled in the study had higher health literacy based on the Short Test of Functional Health Literacy in Adults [33.8 (SD 2.3) versus 27.3 (SD 9.6); p = 0.009] as compared to individuals who previously declined an invitation to enroll in the study. Furthermore, patients with lower Short Test of Functional Health Literacy in Adults scores had larger ( p = 0.04) and older ( p = 0.125) wounds (markers for poorer prognosis). Other measures of literacy showed similar results. In conclusion, those with diminished health literacy were less likely to enroll in an investigational study and had wounds that were less likely to heal. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
41. Interobserver agreement, sensitivity, and specificity of a 'healed' chronic wound.
- Author
-
Margolis, David J., Berlin, Jesse A., and Strom, Brian L.
- Published
- 1996
- Full Text
- View/download PDF
42. Definitions and guidelines for assessment of wounds and evaluation of healing.
- Author
-
Lazarus, Gerald S., Cooper, Diane M., Knighton, David R., Margolis, David J., Percoraro, Roger E., Rodeheaver, George, and Robson, Martin C.
- Published
- 1994
- Full Text
- View/download PDF
43. Quality assessment of tissue specimens for studies of diabetic foot ulcers.
- Author
-
Stojadinovic, Olivera, Landon, Jennifer N., Gordon, Katherine A., Pastar, Irena, Escandon, Julia, Vivas, Alejandra, Maderal, Andrea D., Margolis, David J., Kirsner, Robert S., and Tomic‐Canic, Marjana
- Subjects
DIABETIC foot ,TISSUE analysis ,DIAGNOSTIC specimens - Abstract
Diabetic foot ulcers ( DFUs) represent an important clinical problem resulting in significant morbidity and mortality. Ongoing translational research studies strive to better understand molecular/cellular basis of DFU pathology that may lead to identification of novel treatment protocols. Tissue at the non-healing wound edge has been identified as one of major contributors to the DFU pathophysiology that provides important tool for translational and clinical investigations. To evaluate quality of tissue specimens and their potential use, we obtained 81 DFU specimens from 25 patients and performed histological analyses, immunohistochemistry and RNA quality assessments. We found that depth of the collected specimen is important determinant of research utility, and only specimens containing a full-thickness epidermis could be utilized for immunohistochemistry and RNA isolation. We showed that only two-thirds of collected specimens could be utilized in translational studies. This attrition rate is important for designs of future studies involving tissue specimen collection from DFU. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
44. Defining success in clinical trials of diabetic foot wounds: the Los Angeles DFCon consensus.
- Author
-
Armstrong, David G, Boulton, Andrew JM, Andros, George, Attinger, Christopher, Eisenbud, David, Lavery, Lawrence A, Lipsky, Benjamin A, Mills, Joseph L, Sibbald, Gary, Smith, Adrianne P, Wukich, Dane, and Margolis, David J
- Abstract
Regulatory requirements for new products should be guided by clinical trials that protect the public by a thorough evaluation of safety and efficacy, while not creating unnecessary barriers to their development and ultimate approval. While healing a wound is the ultimate goal of treating an individual with a diabetic foot ulcer, achieving this goal is physiologically complex requiring the initiation and interaction of many events and therefore unlikely to be achieved by one compound. We believe that developing new, more meaningful, study outcomes or end points in wound care trials would both aid in determining the true efficacy of wound management modalities and facilitate the product development cycle. The primary guidance from the US Food and Drug Administration to industry in this field was published in 2006. This document, while helpful and largely in concert with current knowledge of wound healing, needs to be substantially improved. We therefore convened an interdisciplinary task force comprising experts in various aspects of wound care to attempt to achieve consensus in defining primary outcomes and potential secondary endpoints for various classes of wound-healing modalities. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
45. The pitfalls of a purely clinical definition of nephrogenic systemic fibrosis: comment on the article by Todd et al.
- Author
-
Introcaso, Camille E., Brunelli, Steven M., Gelfand, Joel M., Malik, Anuj S., Murashima, Miho, Ahmed, Irfan, Feldman, Harold I., Margolis, David J., Todd, Derrick J., Kay, Jonathan, Sheane, Barry J., Howard, Donough, Doran, Michele F., and Cunnane, Gaye
- Subjects
LETTERS to the editor ,FIBROSIS - Abstract
A letter to the editor is presented in response to an article about nephrogenic systemic fibrosis, by Todd and colleagues in the 2007 issue.
- Published
- 2008
- Full Text
- View/download PDF
46. Endothelial progenitor cell mobilization following acute wound injury.
- Author
-
Fukaya, Eri, Margolis, David J., Miller, Christopher J., Milovanova, Tatyana N., Papadopoulos, Maryte, and Thom, Stephen R.
- Subjects
- *
STEM cells , *ANALYSIS of variance , *NEOVASCULARIZATION , *RESEARCH funding , *T-test (Statistics) , *WOUNDS & injuries , *ACUTE diseases , *DATA analysis software , *DESCRIPTIVE statistics , *PHYSIOLOGY - Abstract
The article discusses a study which investigated endothelial progenitor cell (EPC) mobilization following wound injury. Blood samples were taken from subjects that were enrolled from the dermatologic surgical practice at the University of Pennsylvania (UPenn). The researchers found that a change occurred in the peripheral EPC pool within a 1- to 2-hour time frame.
- Published
- 2013
- Full Text
- View/download PDF
47. Increased bursting in layer 2/3 neurones of awake neocortex.
- Author
-
Margolis, David J.
- Published
- 2008
- Full Text
- View/download PDF
48. Multiple Dermatofibromas in Patients with Autoimmune Disorders Receiving Immunosuppressive Therapy.
- Author
-
Margolis, David J.
- Subjects
LETTERS to the editor ,DERMATOLOGY - Abstract
Presents a letter to the editor in response to the article "Multiple Dermatofibromas in Patients With Autoimmune Disorders Receiving Immunosuppressive Therapy," by P.R. Cohen, published in the 1991 issue of the "International Journal of Dermatology."
- Published
- 1991
- Full Text
- View/download PDF
49. Toxic Epidermal Necrolysis Associated with Sulfonamides.
- Author
-
Goihman-Yahr, Mauricio, Margolis, David J., and Bondi, Edward E.
- Subjects
LETTERS to the editor ,SULFONAMIDES - Abstract
Presents a letter to the editor that focuses on toxic epidermal necrolysis associated with sulfonamides.
- Published
- 1990
- Full Text
- View/download PDF
50. Approach to diagnosing lower extremity ulcers.
- Author
-
Fukaya E and Margolis DJ
- Subjects
- Diabetic Neuropathies diagnosis, Diagnosis, Differential, Humans, Infection Control, Leg Ulcer etiology, Lymphedema diagnosis, Peripheral Arterial Disease diagnosis, Physical Examination, Venous Thrombosis diagnosis, Leg Ulcer diagnosis
- Abstract
Chronic leg ulcers (as differentiated from wound of the foot) are most often due to venous disease, arterial insufficiency (peripheral arterial disease), or a combination of both. Treatment modalities vary depending on the etiology of the ulcer, so it is important to make an appropriate diagnosis of the wound. Like for most medical illnesses, the determination of the etiology of these wounds is based on history, physical examination, and testing., (© 2013 Wiley Periodicals, Inc.)
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.